November 12 from 1:30 pm – 2:15 pm PST
Supported By: GSK
With the release of the latest recommendations from EULAR, our expert panel, Dr. Sheetal Desai, Dr. Alfred Kim, and Dr. Donald Thomas, will hold a lively and interactive discussion about how this recently updated guidance on the earlier use of biologics can be adopted into routine clinical practice. This will include a discussion on how early intervention can help to achieve short-term and long-term treatment objectives in SLE, as well as examine the barriers that need to be overcome to support earlier treatment. Participate in our conversation on the earlier use of biologics, with the goal of improving outcomes for patients with lupus.
This program is developed and offered by GSK. This is not an official program of the American College of Rheumatology.
Donald Thomas, MD, FACP, FACR, RhMSUS
Arthritis and Pain Associates of Prince George’s County
Associate Professor of Medicine at the Uniformed Services University
Sheetal Desai, MD, MSEd, FACR
University of California Irvine
Chief of Rheumatology Division of Rheumatology
Orange County, California
Alfred Kim, MD, PhD
Washington University School of Medicine St. Louis
Assistant Professor of Medicine at WashU School of Medicine
St. Louis, Missouri